Beximco Pharmaceuticals Limited (BXP.L)
GBp 38.0
(1.33%)
GBp 38.0
(1.33%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 10.61 Billion BDT | -14.22% |
| 2021 | 12.37 Billion BDT | 62.1% |
| 2020 | 7.63 Billion BDT | -27.35% |
| 2019 | 10.5 Billion BDT | -22.1% |
| 2018 | 13.48 Billion BDT | 20.54% |
| 2017 | 11.18 Billion BDT | 143.65% |
| 2016 | 4.59 Billion BDT | -4.45% |
| 2015 | 4.8 Billion BDT | 1.83% |
| 2014 | 4.71 Billion BDT | 0.77% |
| 2013 | 4.68 Billion BDT | 27.91% |
| 2012 | 3.66 Billion BDT | -6.04% |
| 2011 | 3.89 Billion BDT | 0.13% |
| 2010 | 3.89 Billion BDT | 5.59% |
| 2009 | 3.68 Billion BDT | 3.61% |
| 2008 | 3.55 Billion BDT | 17.47% |
| 2007 | 3.02 Billion BDT | -4.63% |
| 2006 | 3.17 Billion BDT | -9.7% |
| 2005 | 3.51 Billion BDT | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q3 | 7.42 Billion BDT | -2.31% |
| 2023 Q1 | 8.35 Billion BDT | -21.23% |
| 2023 Q2 | 7.6 Billion BDT | -9.04% |
| 2022 Q2 | 11.5 Billion BDT | -4.22% |
| 2022 FY | 10.61 Billion BDT | -14.22% |
| 2022 Q4 | 10.61 Billion BDT | -6.84% |
| 2022 Q3 | 11.39 Billion BDT | -0.98% |
| 2022 Q1 | 12.01 Billion BDT | -2.91% |
| 2021 Q2 | 11.03 Billion BDT | -1.06% |
| 2021 Q3 | 11.83 Billion BDT | 7.19% |
| 2021 Q4 | 12.37 Billion BDT | 4.57% |
| 2021 FY | 12.37 Billion BDT | 62.1% |
| 2021 Q1 | 11.15 Billion BDT | 46.16% |
| 2020 Q4 | 7.63 Billion BDT | -8.54% |
| 2020 Q3 | 8.34 Billion BDT | -6.63% |
| 2020 Q2 | 8.93 Billion BDT | -6.8% |
| 2020 Q1 | 9.58 Billion BDT | -8.71% |
| 2020 FY | 7.63 Billion BDT | -27.35% |
| 2019 Q2 | 10.86 Billion BDT | -7.92% |
| 2019 Q1 | 11.8 Billion BDT | -12.47% |
| 2019 Q4 | 10.5 Billion BDT | -8.75% |
| 2019 Q3 | 11.51 Billion BDT | 5.92% |
| 2019 FY | 10.5 Billion BDT | -22.1% |
| 2018 Q2 | 11.37 Billion BDT | 3.58% |
| 2018 Q1 | 10.97 Billion BDT | -1.87% |
| 2018 Q4 | 13.48 Billion BDT | 21.87% |
| 2018 FY | 13.48 Billion BDT | 20.54% |
| 2018 Q3 | 11.06 Billion BDT | -2.69% |
| 2017 Q3 | 7.28 Billion BDT | 44.32% |
| 2017 Q2 | 5.04 Billion BDT | 17.74% |
| 2017 Q1 | 4.28 Billion BDT | -6.67% |
| 2017 FY | 11.18 Billion BDT | 143.65% |
| 2017 Q4 | 11.18 Billion BDT | 53.64% |
| 2016 Q4 | 4.59 Billion BDT | -0.79% |
| 2016 Q2 | 4.42 Billion BDT | 9.04% |
| 2016 Q3 | 4.62 Billion BDT | 4.61% |
| 2016 Q1 | 4.05 Billion BDT | -4.28% |
| 2016 FY | 4.59 Billion BDT | -4.45% |
| 2015 Q4 | 4.23 Billion BDT | 0.0% |
| 2015 Q1 | 5.01 Billion BDT | 1.16% |
| 2015 FY | 4.8 Billion BDT | 1.83% |
| 2015 Q2 | 4.64 Billion BDT | -7.38% |
| 2014 Q4 | 4.95 Billion BDT | 4.35% |
| 2014 Q3 | 4.75 Billion BDT | 0.72% |
| 2014 Q2 | 4.71 Billion BDT | -2.36% |
| 2014 Q1 | 4.83 Billion BDT | 1.91% |
| 2014 FY | 4.71 Billion BDT | 0.77% |
| 2013 Q1 | 3.3 Billion BDT | 2.64% |
| 2013 Q2 | 4.68 Billion BDT | 41.77% |
| 2013 Q3 | 4.66 Billion BDT | -0.43% |
| 2013 Q4 | 4.74 Billion BDT | 1.7% |
| 2013 FY | 4.68 Billion BDT | 27.91% |
| 2012 Q1 | 3.29 Billion BDT | 0.0% |
| 2012 Q3 | 3.65 Billion BDT | -0.12% |
| 2012 FY | 3.66 Billion BDT | -6.04% |
| 2012 Q4 | 3.21 Billion BDT | -11.99% |
| 2012 Q2 | 3.66 Billion BDT | 11.19% |
| 2011 Q2 | 3.89 Billion BDT | 1.31% |
| 2011 FY | 3.89 Billion BDT | 0.13% |
| 2011 Q1 | 3.84 Billion BDT | 0.34% |
| 2010 Q4 | 3.83 Billion BDT | -1.8% |
| 2010 Q1 | 3.93 Billion BDT | -0.12% |
| 2010 Q2 | 3.89 Billion BDT | -1.19% |
| 2010 Q3 | 3.9 Billion BDT | 0.32% |
| 2010 FY | 3.89 Billion BDT | 5.59% |
| 2009 Q1 | 4.14 Billion BDT | 11.33% |
| 2009 Q4 | 3.94 Billion BDT | 5.93% |
| 2009 Q3 | 3.72 Billion BDT | 1.01% |
| 2009 Q2 | 3.68 Billion BDT | -11.08% |
| 2009 FY | 3.68 Billion BDT | 3.61% |
| 2008 Q2 | 3.55 Billion BDT | 0.0% |
| 2008 Q4 | 3.72 Billion BDT | 0.0% |
| 2008 FY | 3.55 Billion BDT | 17.47% |
| 2007 Q2 | 3.02 Billion BDT | 0.0% |
| 2007 FY | 3.02 Billion BDT | -4.63% |
| 2007 Q4 | 3.25 Billion BDT | 0.0% |
| 2006 FY | 3.17 Billion BDT | -9.7% |
| 2005 FY | 3.51 Billion BDT | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|